Study title: An open-label, multicenter, single-dose study to evaluate the pharmacokinetics of glimepiride (Amaryl®) in pediatric patients with type 2 diabetes mellitus - Sponsor Sanofi - 26/02/2004
| Type of medicine: Medicines containing chemical active substances | |||||
| Therapeutic area: Nutritional and Metabolic Diseases [C18] | |||||
| Brands: Please see report | |||||
| MAH holders: Please see report | |||||
| Assessment: | |||||
| Active substance: GLIMEPIRIDE | |||||
| ATC code: | |||||
| Document link: Glimepiride-Study 2.pdf | |||||
| Document date: 2011-09-23 | |||||
| Study number: HOE 490/4045 | |||||
| EudraCT number: | |||||
| Scope of study: Clinical | |||||
| Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
| - | - | - | Y | Y | |